Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine Pretreatment for IV Contrast Pain in Children
NCT05143489Phase 4Terminated
- Start
- Jan 2022
- Primary completion
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in pain comparing Lidocaine Group with Placebo Group (2 arms). Primary endpoint: Pain Score. Started Jan 2022; status: terminated.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
03
Conditions
pain
Beyond the preview
Go deeper on NCT05143489.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05143489.